[KROS] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
30-Dec-2019
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 22.49%
YoY-
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 2,500 2,500 2,500 2,500 2,500 2,500 2,500 0.00%
PBT -12,036 -10,757 -12,064 -2,751 -3,549 -2,853 -3,183 142.12%
Tax -156 1 -172 2,302 -1,217 2 2 -
NP -12,036 -10,757 -11,892 -2,751 -3,549 -2,853 -3,183 142.12%
Tax Rate - - - - - - - -
Total Cost 14,536 13,257 14,392 5,251 6,049 5,353 5,683 86.71%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -481.44 -430.28 -475.68 -110.04 -141.96 -114.12 -127.32 142.12%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.60 -0.61 -0.65 -0.31 -0.40 -0.32 -0.36 40.44%
EPS Diluted -0.60 -0.61 -0.65 -0.31 -0.40 -0.32 -0.36 40.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.